Evidence map›Paper›PMID 41388170›Full record

ArticleAesthetic plastic surgery2026

When Genes Meet Gels: Computational Immunogenetics of Dermal Fillers and Stratified Risk of Immune and Fibrotic Reactions across Compositions and Genotypes.

Eqram Rahman, Parinitha Rao, Alain Michon, Sotirios Ioannidis, Woffles T L Wu, Jean D A Carruthers, William Richard Webb

Abstract read
PubMed Publisher
In one paragraph

Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eqram RahmanResearch and Innovation Hub, Innovation Aesthetics, London, WC2H 9JQ, UK. Eqram.rahman@gmail.com.ORCID 0000-0002-8443-8338
Parinitha RaoThe Skin Address, Aesthetic Dermatology Practice, Bangalore, India.
Alain MichonThe Ottawa Skin Clinic/Project Skin MD Ottawa, Ottawa, ON, Canada.
Sotirios IoannidisPlastic Surgery Clinic, 546 21, Thessaloniki, Greece.
Woffles T L WuWoffles Wu Aesthetic Surgery and Laser Centre 1, Camden Medical Centre Singapore, Orchard Boulevard Suite 09-02, Singapore, Singapore.
Jean D A CarruthersDepartment of Ophthalmology, University of British Columbia, Vancouver, BC, Canada.
William Richard WebbResearch and Innovation Hub, Innovation Aesthetics, London, WC2H 9JQ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelayed inflammatory and fibrotic reactions to dermal fillers remain unpredictable, reflecting complex interactions between product composition and host genetics.

objectiveTo develop and validate a computational framework integrating filler physicochemical attributes with simulated genetic variation to estimate relative immunologic and fibrotic risk across commercially available products.

methodsTwenty-six fillers were analysed using a hierarchical Bayesian model combining rheologic, structural, and compositional parameters with genotype-specific modifiers in AesthetiSIM™, a reproducible Docker-based environment. Posterior distributions were derived for biostimulatory, immunogenic, and fibrotic indices, and composite scores were normalized to the [0-1] interval. Sensitivity analyses included exposure-adjusted validation, leave-one-product-out cross-validation, and variance decomposition to assess robustness.

resultsRisk scores formed a continuous spectrum. Profhilo, Juvéderm Volite, Voluma XC, and Evolysse™ SMOOTH occupied the lowest strata (mean < 0.15), whereas Sculptra, Radiesse, and HArmonyCa showed the highest (mean > 0.75). The scores quantify relative risk gradients rather than absolute event probabilities. Cluster and heatmap analyses revealed distinct mechanistic classes consistent with known material properties.

conclusionDermal filler safety exists on a graded continuum determined jointly by composition and genetic susceptibility. This integrative, reproducible model provides an evidence-organized framework for personalized product selection and informed patient counselling in precision aesthetic practice. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Indexed as

Cosmetic TechniquesDermal FillersBayes TheoremFemaleFibrosisGenotypeHumansImmunogeneticsRisk AssessmentDermal FillersBiostimulatory fillersCalcium hydroxylapatiteComputational modellingDermal fillersGenetic susceptibilityHyaluronic acidImmunogenicityPoly-L-lactic acidRheology

Identifiers

PMID41388170

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.